Cambridge Advisors Inc. Abb Vie Inc. Transaction History

Cambridge Advisors Inc.

$446 Million
Q3 2024

A detailed history of Cambridge Advisors Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cambridge Advisors Inc. holds 8,775 shares of ABBV stock, worth $1.45 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

8,775

Previous 8,840 0.74%

Holding current value

$1.45 Million

Previous $1.52 Million 14.25%

% of portfolio

0.39%

Previous 0.36%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$163.84 - $199.33 $10,649 - $12,956	-65 Reduced 0.74%	8,775 $1.73 Million
Q2 2024 Jul 11, 2024	BUY	$154.79 - $180.76 $10,061 - $11,749	65 Added 0.74%	8,840 $1.52 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $95,892 - $109,260	-600 Reduced 6.4%	8,775 $1.6 Million
Q4 2023 Jan 16, 2024	SELL	$137.6 - $154.97 $27,520 - $30,994	-200 Reduced 2.09%	9,375 $1.45 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $67,462 - $78,098	-505 Reduced 5.01%	9,575 $1.43 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $143,773 - $178,916	-1,085 Reduced 9.72%	10,080 $1.36 Million
Q1 2023 Apr 13, 2023	BUY	$144.61 - $166.54 $7,230 - $8,327	50 Added 0.45%	11,165 $1.78 Million
Q4 2022 Jan 23, 2023	SELL	$138.31 - $165.87 $48,408 - $58,054	-350 Reduced 3.05%	11,115 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $6,710 - $7,696	-50 Reduced 0.43%	11,465 $1.54 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $32,065 - $40,765	-233 Reduced 1.98%	11,515 $1.76 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $4,883 - $6,058	-37 Reduced 0.31%	11,748 $1.9 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $42,972 - $54,372	400 Added 3.51%	11,785 $1.6 Million
Q3 2021 Oct 19, 2021	SELL	$106.4 - $120.78 $24,578 - $27,900	-231 Reduced 1.99%	11,385 $1.23 Million
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $28,827 - $32,115	-274 Reduced 2.3%	11,616 $1.31 Million
Q1 2021 Apr 22, 2021	BUY	$102.3 - $112.62 $102 - $112	1 Added 0.01%	11,890 $1.29 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $80 - $108	1 Added 0.01%	11,889 $1.27 Million
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $171 - $201	2 Added 0.02%	11,888 $1.04 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $73 - $98	1 Added 0.01%	11,886 $1.17 Million
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $33,862 - $51,339	525 Added 4.62%	11,885 $906,000
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $28,852 - $36,100	-400 Reduced 3.4%	11,360 $1.01 Million
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $3,778 - $4,543	-60 Reduced 0.51%	11,760 $890,000
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $3,857 - $4,539	-50 Reduced 0.42%	11,820 $953,000
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $7,784 - $9,601	100 Added 0.85%	11,870 $1.09 Million
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $26,673 - $29,652	-300 Reduced 2.49%	11,770 $1.11 Million
Q1 2018 Apr 18, 2018	SELL	$92.01 - $123.21 $24,382 - $32,650	-265 Reduced 2.15%	12,070 $1.14 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $861,599 - $1.1 Million	12,335	12,335 $1.1 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.

Account

Cambridge Advisors Inc. Abb Vie Inc. Transaction History